ESR1 and neoplasm: To better model the clinical scenario of our treatments, two ER+ patient-derived xenograft (PDX) models were grown subcutaneously in NSG mice, one from an early (HBCx34, [19]) and another from a metastatic tumor (BB3RC31, [20]).